We are live on ! Find out more
First Trust Advisors

First Trust Advisors Portfolio holdings

AUM $170B
1-Year Est. Return 46.21%
This Fund
S&P 500
This Quarter Est. Return
+12.23%
1 Year Est. Return
+46.21%
3 Year Est. Return
+117.8%
5 Year Est. Return
+135.17%
10 Year Est. Return
+698.25%
AUM
$124B
AUM Growth
+$11.4B
Cap. Flow
+$944M
Cap. Flow %
0.76%
Top 10 Hldgs %
10.89%
Holding
2,727
New
194
Increased
1,215
Reduced
1,167
Closed
142

Sector Composition

Rank Sector Weight
1 Technology 29.62%
2 Financials 15.15%
3 Industrials 14.51%
4 Consumer Discretionary 8.27%
5 Healthcare 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAK icon
651
Takeda Pharmaceutical
TAK
$55.5B
$40.2M 0.03%
2,601,808
-154,147
-6% -$2.28M
EMA
652
Emera Inc
EMA
$15.8B
$40.2M 0.03%
+877,444
New +$39.4M
GBX icon
653
The Greenbrier Companies
GBX
$1.42B
$40.2M 0.03%
872,748
+346,039
+66% +$15.5M
DT icon
654
Dynatrace
DT
$14.7B
$40.1M 0.03%
726,094
+338,845
+88% +$17M
ALKS icon
655
Alkermes
ALKS
$8.3B
$40M 0.03%
1,397,281
-223,765
-14% -$6.66M
HALO icon
656
Halozyme
HALO
$11.4B
$39.8M 0.03%
765,918
-37,776
-5% -$2.15M
MTD icon
657
Mettler-Toledo International
MTD
$28.7B
$39.8M 0.03%
33,900
+448
+1% +$501K
RPRX icon
658
Royalty Pharma
RPRX
$26.1B
$39.8M 0.03%
1,104,044
-495,192
-31% -$16.4M
ENPH icon
659
Enphase Energy
ENPH
$5.39B
$39.7M 0.03%
1,000,413
+31,403
+3% +$1.45M
CORT icon
660
Corcept Therapeutics
CORT
$11.9B
$39.4M 0.03%
537,186
-387,131
-42% -$28.1M
FDX icon
661
FedEx
FDX
$80.3B
$39.2M 0.03%
172,550
+37,298
+28% +$8.17M
BRKR icon
662
Bruker
BRKR
$8.78B
$39.2M 0.03%
951,802
+257,755
+37% +$9.95M
ENB icon
663
Enbridge
ENB
$111B
$39.1M 0.03%
863,703
-82,075
-9% -$3.72M
AEIS icon
664
Advanced Energy
AEIS
$13.1B
$39.1M 0.03%
294,775
+24,422
+9% +$2.69M
SXT icon
665
Sensient Technologies
SXT
$5.53B
$39M 0.03%
396,086
-179,601
-31% -$16.1M
CMA
666
DELISTED
Comerica
CMA
$39M 0.03%
654,103
+69,392
+12% +$3.87M
BAX icon
667
Baxter International
BAX
$14B
$39M 0.03%
1,287,832
-250,792
-16% -$7.6M
CNI icon
668
Canadian National Railway
CNI
$77.2B
$39M 0.03%
374,763
-44,504
-11% -$4.53M
PR
669
Permian Resources
PR
$17.8B
$38.9M 0.03%
2,854,877
+348,458
+14% +$4.48M
K
670
DELISTED
Kellanova
K
$38.8M 0.03%
487,843
-284,946
-37% -$23.3M
EXAS
671
DELISTED
Exact Sciences
EXAS
$38.8M 0.03%
729,930
-18,983
-3% -$964K
HMC icon
672
Honda
HMC
$40.5B
$38.7M 0.03%
1,343,158
-45,534
-3% -$1.33M
BBY icon
673
Best Buy
BBY
$18B
$38.7M 0.03%
576,824
-93,598
-14% -$6.36M
CHRD icon
674
Chord Energy
CHRD
$7.35B
$38.7M 0.03%
399,628
+11,785
+3% +$1.12M
GSK icon
675
GSK
GSK
$101B
$38.6M 0.03%
1,004,799
-71,321
-7% -$2.73M

Similar funds

First Trust Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, First Trust Advisors held 2,727 positions worth $124B, up 10% from $113B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

First Trust Advisors's Q2 2025 filing shows 194 new, 1,215 increased, 1,167 reduced and 142 closed positions. Its largest new stake was First Trust NASDAQ 100 ex-Technology Sector Index Fund: 7,413,411 shares worth $732M. The largest sale was First Trust NASDAQ-100 Technology Index Fund, an estimated $698M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Industrials.

  • First Trust Advisors's largest Q2 2025 buy was First Trust NASDAQ 100 ex-Technology Sector Index Fund: 7,413,411 shares worth $732M.
  • First Trust Advisors added most to ExxonMobil in Q2 2025, an estimated $488M increase.
  • First Trust Advisors's biggest Q2 2025 reduction was Philip Morris, cutting an estimated $400M.
  • First Trust Advisors fully exited First Trust NASDAQ-100 Technology Index Fund in Q2 2025, selling an estimated $698M.
  • First Trust Advisors's ten largest holdings make up 11% of its $124B portfolio in Q2 2025.
  • First Trust Advisors opened 194 new positions and closed 142 in Q2 2025.
  • First Trust Advisors's portfolio value rose 10% quarter-over-quarter to $124B.

Based on First Trust Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.